www.zuelligpharma.com Open in urlscan Pro
2a02:26f0:12d::b819:ef69  Public Scan

Form analysis
1 forms found in the DOM

Name: hrefFm — POST #

<form action="#" aria-hidden="true" class="hide" id="hrefFm" method="post" name="hrefFm"><span></span><button hidden="" type="submit">Hidden</button></form>

Text Content

Skip to Main Content
Zuellig Pharma
Sign In
Contact Us
 * About Us
   About Us
    * Purpose & Core Values
    * Leadership
    * Heritage & Milestones
    * Ethics & Compliance
    * Quality
    * Sustainability
    * Procurement

 * Solutions
   Solutions
    * Distribution
    * ZP Therapeutics
    * Clinical Reach
    * Technology Solutions
    * Patient Solutions
    * Regulatory Services

 * Segments
   Segments
    * Pharmaceuticals
    * Medical Devices & Diagnostics
    * Consumer Healthcare
    * Animal Health
    * Specialty Care
    * Vaccines

 * News & Insights
 * Careers
 * Contact Us

How can we help you?
Search
Please enter a search value...
How can we help you?
Search
Please enter a search value...
Contact Us


MAKING HEALTHCARE MORE ACCESSIBLE IN ASIA

Zuellig Pharma provides world-class pharmaceutical distribution, digital and
commercial services to support the evolving healthcare needs in the region.

 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 

UNLOCK THE POTENTIAL OF ASIA WITH ZUELLIG PHARMA'S UNIQUE HEALTHCARE SOLUTIONS.

Select Market
 * Australia
 * Brunei
 * Cambodia
 * China
 * Hong Kong & Macau
 * India
 * Indonesia
 * Japan
 * Korea
 * Malaysia
 * Myanmar
 * Philippines
 * Singapore
 * Taiwan
 * Thailand
 * Vietnam

Zuellig Pharma's depot in South Australia is a TGA-licensed facility that is
approximately 1,300 sq.m. The facility has managed over 1,000 clinical trials
since its foundation and currently manages more than 350 clinical trials. 

OPPORTUNITIES

 * Brunei's government tenders make up 70% of healthcare business.
 * Thriving retail business with potential for chain pharmacy expansion.
 * Growing oncology opportunities in public and private sectors.
 * Potential for Brunei's Ministry to plan, promote, and develop medical
   tourism.
 * Increasing demand for health and medical services due to ageing population.

CAPABILITIES

 * Leading healthcare provider in Brunei with 36 years of experience as only
   foreign invested company.
 * Largest distributor and market leader, serving 9 of top 10 pharma clients in
   Brunei.
 * Excellent RA capabilities, holding market authorisation for 25% of registered
   medicinal products with MOH.
 * Innovative, automated warehouse system handles 80% of biologics and cold
   chain products in Brunei.
 * Robust tender management team with excellent track record in handling MOH
   tenders at scale.

Zuellig Pharma's Cambodia facilities offer a newly-built distribution centre
with an over 6,300 sq.m. warehouse and 1,200 sq.m. mezzanine for healthcare
products, including 6,400 pallets in 6-high racking and 240 cold room storage
pallets. With 90% coverage of ethical, pharmacy, and modern trade, we serve over
10,000 healthcare customers nationwide, including hospitals, clinics, and
pharmacies, through 200 sales and marketing representatives. Our quality of work
is recognised with certifications such as GDSP, GMP, GDPMDD, and ISO 9001:2015. 

OPPORTUNITIES

 * Expansion of universal healthcare boosts medical services utilisation.
 * NGOs continue to provide essential medicines.
 * Basic medicines are vital due to regional production and low domestic
   manufacturing.
 * Total pharmaceutical sales reached USD 386M in 2022 with per capita spending
   at USD 23.
 * Pharmaceutical consumption rises to treat growing prevalence of chronic
   lifestyle diseases.

CAPABILITIES

 * Zuellig Pharma has 20 years' experience as healthcare provider in Cambodia,
   serving four top 10 Pharma clients.
 * Largest cold-room facility in Cambodia with state-of-the-art infrastructure
   for healthcare.
 * Proven cold chain tech maintains optimal quality during delivery.
 * Passive packaging with unique thermal isolation chamber system.
 * Patient-centric affordability and adherence programs.
 * Custom mobile app for client program admin, enrolments, and updates.

Zuellig Pharma has two warehouses in Hong Kong spanning over 48,000 sq.m.,
offering air-conditioned storage for 24,000 pallets and cold chain storage for
800 pallets. We serve 10,000+ healthcare customers, including hospitals,
clinics, dentists, and drug stores. Zuellig Pharma moves 48,000 cubic meters of
products annually and has won awards such as the HR Distinction Awards -
Excellence in Employee Wellbeing and Occupational Health Award - Excellence
Award of Joyful@Healthy Workplace Best Practices Award. 

OPPORTUNITIES

 * Opportunities in China GBA for Hong Kong drugs and medical devices in public
   hospitals
 * Predicted 3.5%-5.5% economic growth for Hong Kong in 2023
 * High life expectancy in Hong Kong due to advanced healthcare and health
   consciousness
 * Aging population driving demand for healthcare services and products
 * Increased demand for consumer health post-COVID-19 due to raised health
   consciousness
 * Smart hospitals and telehealth offer innovative and sustainable solutions for
   growing service demand.

CAPABILITIES

 * Over 40 years healthcare experience in Hong Kong
 * Expert in healthcare solutions from storage to delivery
 * Specialised in cold chain storage and distribution with certified facilities
 * Over 20 years of vaccine and vaccination program experience
 * Strong relationships with top healthcare companies in Hong Kong & Macau
 * DoH approved and GMP certified secondary repackaging facilities.

Zuellig Pharma provides complete coverage of ethical, pharmacy, and modern trade
products in Indonesia, serving over 26,000 direct outlets with over 2,800
trained employees, 25 warehouses, 4 sales offices, and 8 APL partners'
locations. The team has amassed numerous accolades, such as the HR Asia Best
Companies to Work for in Asia and CNBC Indonesia Outstanding Company in
Sustainability-Community Initiative awards. 

OPPORTUNITIES

 * Indonesia launched its first digital health blueprint, aiming to expand
   inclusive healthcare coverage for its 270M population.
 * The blueprint will help Indonesia accelerate its national goal of providing
   universal, affordable, equitable and quality care to all its citizens, using
   digital technologies.

CAPABILITIES

 * Zuellig Pharma offers integrated healthcare solutions in Indonesia, including
   distribution, commercialisation, patient care, data analytics, and
   importation.
 * APL National Distribution Centre is the largest Pharma-grade warehouse in
   Indonesia, with 54,000 sq.m. space for pharma, consumer, and medical
   products.
 * Over 13,000 orders are handled daily by 550 certified personnel, with 6,000
   orders delivered via 200+ vehicles.
 * The highest cold chain standards in Indonesia, with over 2,000 sq.m., 33 cold
   rooms, and 85 chillers.

Zuellig Pharma's Korea facilities comprise 12 warehouses and a team of 150 sales
and marketing representatives serving over 36,000 healthcare customers
nationwide. We have received various accolades and certifications for
sustainability, transparency in pharmaceutical distribution, and industry
leadership.

OPPORTUNITIES

 * Strong healthcare system and popular medical tourism market.
 * Booming digital health sector with patient-focused innovation.
 * High purchasing power and one of the highest GDP per capita in APAC region.
 * Rapidly expanding pharmaceutical industry with USD 17.9B reach and 9.6% CAGR
   in 2021.
 * Thriving medical device industry with USD 7.9B reach and 10.6% CAGR in 2021,
   ranking 9th globally.
 * Ageing population with growing healthcare demands.
 * Increasingly recognised as a key destination for clinical trials in the Asian
   pharmaceutical market.

CAPABILITIES

 * 25 years experience as a healthcare service provider in South Korea.
 * Operate South Korea’s largest cold-room facility.
 * South Korea’s largest specialty and vaccine distributor, and Asia’s clinical
   logistics leader.
 * Preferred go-to commercialisation partner for high compliance standards and
   transparency.
 * Customised technology solutions for eCommerce, block-chain, and business
   analytics.

Zuellig Pharma's Malaysia facilities include a main warehouse in Bukit Jelutong
and an approximately 7,000 sq.m. warehouse for dialysis solutions, medical
supplies, and surgical lenses. With two branch offices and a branch warehouse,
Zuellig Pharma has 100% coverage of hospitals, clinics, and pharmacies with over
15,000 customers across Malaysia. We have won numerous awards for quality and
certifications. 

OPPORTUNITIES

 * Quality healthcare system, top global medical tourism market.
 * Growing patient-centric digital health innovation in Malaysia.
 * High allocation from Budget 2023 for healthcare.
 * Medical device industry to reach USD 2.2B in 2023.
 * Ageing population driving increasing demand for healthcare services.

CAPABILITIES

 * 84 years experience as healthcare provider in Malaysia.
 * Largest cold chain facility, eZCooler as an advanced passive packaging
   solution.
 * End-to-end integrated solutions for entire healthcare value chain.
 * Actively drive sustainability and partner with clients on special projects to
   meet carbon savings objectives.

Zuellig Pharma's Myanmar facilities provide comprehensive coverage of ethical,
pharmacy, and modern trade services with over 90% reach. Our facilities are
certified in GDSP, GMP, and ISO, ensuring top-quality cold chain facilities,
passive packaging, and patient-centric programs for affordability and adherence.
With over 4,000 healthcare customers nationwide and a team of 90 highly-trained
sales representatives, we offer exceptional service. 

OPPORTUNITIES

 * National health insurance system reduces healthcare expenses and improves
   accessibility.
 * Companies Act encourages foreign investment in the pharmaceutical sector.
 * National efforts combat malnutrition, undernutrition, and obesity through
   health and educational programs.
 * International aid packages boost local health facilities in combating
   COVID-19.

CAPABILITIES

 * Zuellig Pharma has 8 years of experience in Myanmar, serving 6 out of the top
   10 pharma clients.
 * Our top-notch cold-room facilities use advanced infrastructure.
 * Our cold chain transport tech and packaging use thermal isolation chambers
   for quality maintenance.
 * We provide patient-centric solutions for affordability and adherence.
 * Custom mobile apps are available for client program administration and
   real-time updates.

Zuellig Pharma in the Philippines has seven distribution warehouses covering
over 59,000 sq.m. of distribution centre space for pharma, consumer, medical
devices, and diagnostics products. We have over 1,700 employees nationwide and
have distributed to over 19,000 physicians, 700 private hospitals, 7,000 chain
drug stores, and more. We have been recognised for our quality of work and
sustainability efforts. 

OPPORTUNITIES

 * Ophthalmology agency business shows consistent growth building on B&L.
 * Diagnostic and consumable business is rapidly growing, currently 53% SOB in
   MDI.
 * Animal health business is rapidly growing, especially in the pet segment.
 * Capitalising on client relationships to drive commercialisation initiatives.
 * Potential to improve awareness and utilisation of value-added services (VAS)
   for higher operating revenue and client conversion.

CAPABILITIES

 * Over 100 years of experience in pharma distribution in the Philippines.
 * 100% coverage of hospitals, pharma, modern trade accounts & 50k+ customers
   nationwide.
 * Strong market presence in 86 therapeutic classes.
 * Wide range of services incl. Repackaging, Samples Distribution, Product
   Destruction & Trade Marketing (CHC).
 * Innovative tech solutions incl. eZHealth, eZRx & e-Commerce solutions.
 * Patient-centric programs for adherence, access & affordability.

Zuellig Pharma's Singapore facilities cover over 44,000 sq.m. across three
warehouses and serve over 6,000 healthcare customers with extensive ethical,
pharmacy, and modern trade coverage. We have received various accolades and
certifications, such as the HR Asia Best Companies to Work (2020) for Singapore,
IDC Future Enterprise Awards (2022), and National Awards (COVID-19) 2022
recipient for President's Certificate of Commendation for Singapore.

OPPORTUNITIES

 * Top destination for medical tourism with excellent healthcare.
 * Singapore driving patient-centred innovations in digital health.
 * High GDP per capita reflects strong purchasing power in APAC.
 * Medical device industry projected to reach USD 3.5B by 2022.
 * Increasing demand for health services due to ageing population.

CAPABILITIES

 * Zuellig Pharma delivers 85+ years of healthcare excellence in Singapore.
 * Largest cold-room facility with innovative infrastructure.
 * Top secondary repackager with serialisation capability.
 * Patient-centric programmes for affordability and adherence, with custom
   mobile app.
 * Tailored technology solutions for eCommerce, blockchain and analytics.

Zuellig Pharma in Taiwan boasts five warehouses spanning over 65, 000 sq.m. and
catering to pharmaceuticals, consumer goods, and medical devices. We offer 100%
coverage of ethical, pharmacy, and modern trade services, serving 20,000+
healthcare customers with over 200 sales and marketing representatives. We have
received accolades like the National Healthcare Quality Award and
National Biotechnology and Medicine Care Quality Award. 

OPPORTUNITIES

 * National health insurance budget growing at 2.9% - 4.5% annual rate.
 * Strong digitalisation trend in health sector, particularly in telemedicine
   and AI diagnosis.
 * Mature environment for clinical trials phases 1-3.
 * Government-funded local biotech companies researching and manufacturing.
 * Increasing healthcare demands due to ageing population and low fertility
   rate.

CAPABILITIES

 * Over 35 years of healthcare experience in Taiwan.
 * Strong relationships with 90+ multinational healthcare companies.
 * Taiwan's only ultra-low cold chain system and largest cold chain storage.
 * Patient care team of 50 nurses serving 60,000+ patients.
 * Customised eZ-solution app for program administration and real-time updates.

Zuellig Pharma runs four warehouses in Thailand, with 56,400 pallet storage
space and a full range of temperature-controlled cold chain rooms for various
products. We offer 98% customer coverage of ethical, pharmacy, and OTC, serving
over 22,000 healthcare customers with 500 sales and marketing representatives,
and have distributed 87% of vaccines to date. We have received numerous
accolades, including nine awards at the 2022 TCCTA Contact Center Awards. 

OPPORTUNITIES

 * Rising demand for healthcare due to increased focus on personal health and
   COVID-19.
 * Ageing population in Thailand leads to increased treatment for chronic
   diseases.
 * Universal Health Coverage scheme provides broad coverage, with return of
   foreign patients.

CAPABILITIES

 * Zuellig Pharma has 75+ years of healthcare experience in Thailand.
 * Largest cold-chain facility for healthcare products with various temperature
   protocols.
 * Fleet of air-conditioned transportation vans with innovative eZCooler
   packaging.
 * One-stop-service for redressing under GMP.

Zuellig Pharma's Vietnam facilities comprise five warehouses with over 23,000 AC
pallets and 1,700 CC pallets, catering to various healthcare products. We
provide 100% coverage across all medical channels, serving over 60,000
healthcare customers. Our certifications include GDP, GCP, GMP, GSP and GSDP,
GDPMD, ISMS, and ISO.

OPPORTUNITIES

 * Ageing population drives long-term demand for prescription drugs.
 * Growing middle class leads to increasing demand for quality healthcare
   services.
 * Significant contribution from imported pharmaceuticals, APIs, and medical
   devices.
 * Abundance of M&A opportunities across healthcare verticals.

CAPABILITIES

 * Over 30 years healthcare service experience in Vietnam.
 * Facilities in Vietnam meet FM Global Platinum standards and use efficient
   energy features.
 * Patient-centric programs for affordability and adherence.
 * 100% direct tender penetration and 99% sales coverage through call plans for
   retail channels.
 * Comprehensive ordering platforms and technology consulting services.

Zuellig Pharma's depot in South Australia is a TGA-licensed facility that is
approximately 1,300 sq.m. The facility has managed over 1,000 clinical trials
since its foundation and currently manages more than 350 clinical trials. 

OPPORTUNITIES

 * Clinical Trial Supplies Market to reach USD 5.7B by 2027.
 * Healthcare CROs market in Australia and New Zealand valued at USD 1B in 2022.
 * CAGR of 11.5% expected for healthcare CROs market from 2023-2030.
 * Virtual clinical trials adoption to drive CRO industry growth in the region.
 * Clinical trials in Australia offer R&D tax advantages and cost efficiency,
   driving industry growth.

CAPABILITIES

 * Global depot & cold chain logistics for reliable healthcare delivery.
 * Sophisticated temperature-controlled. infrastructure adhering to industry
   standards (GDP, GMP, CSV, HSE).
 * Smart Sourcing Solution for unparalleled access to medicine, incl. controlled
   drugs.
 * Specialised cold chain for temperature-sensitive materials.
 * Innovative patient-centric approach to clinical trials with depot-to-patient
   solutions.

Zuellig Pharma's facility in India is strategically-located in Mumbai to ensure
that products and services are made available with the shortest leadtime.
Covering over 1,530 sq.m., the facility offers one-stop solutions for every
client's clinical trial needs, including a global depot and cold chain logistics
network with temperature-controlled infrastructure and GDSP and GMP facilities
for fast product and service availability. India is a cost-efficient and
profitable market for major pharma, and biotech companies, as well as CROs, with
local models meeting country standards.

OPPORTUNITIES

 * Clinical trial industry in India to grow at 8.2% per annum until 2030.
 * Consistent patient population and easy access to modern medical technology in
   India.
 * India offers a favorable currency exchange rate for pharma and biotech
   companies.
 * Major pharma and biotech companies and CROs operate in India, incorporating
   local models to meet country standards, making it a cost-efficient and
   profitable market.

CAPABILITIES

 * Zuellig Pharma has a global depot and cold chain logistics network with
   advanced temperature-controlled facilities and GDSP and GMP facilities.
 * Smart Sourcing Solution provides access to medicines and ancillaries,
   including controlled drugs.
 * Specialised cold chain solutions available for temperature-sensitive
   materials.
 * Strong Quality Management System (QMS) and operational excellence processes
   with a qualified team to offer CTSM services.

Zuellig Pharma China's Beijing facility, with 20 years of clinical supply
experience, is GDP/GMP compliant and a trusted partner for various clients in
clinical trials, including pharmaceutical companies, CROs, CMOs,
biopharmaceutical firms, medical device companies, and diagnostic firms. 

OPPORTUNITIES

 * China's pharmaceutical market to reach USD 161.8B by 2023, accounting for 30%
   of global market.
 * Ageing population and increased life expectancy driving rising demand for
   healthcare in China.
 * Pharma sales in China projected to grow by 4.04% in 2022 and 3.58% in 2023.
 * Chinese government promoting industry consolidation to regulate and control
   drug pricing.
 * China imports biotechnology pharmaceuticals to meet growing domestic demand.

CAPABILITIES

 * Reliable global cold chain logistics network
 * Sophisticated GDSP and GMP temperature-controlled facilities
 * Smart sourcing solution for unparalleled medicine access
 * Specialised cold chain solutions for sensitive materials in clinical storage
 * Central distribution service for global studies
 * Tailored repackaging services with multilingual labels

Zuellig Pharma has an impressive partner depot facility in Japan, covering a
total area of around 1.2 million sq.m., out of which 300,000 sq.m. are solely
dedicated to pharmaceutical handling. Apart from its extensive size and
specialisation, the partner depot also prioritises sustainability, evident
through the installation of solar power generation systems and nighttime heat
storage type air conditioning systems in all its offices.

OPPORTUNITIES

 * Japan's ¥10-trillion (USD 75B) national endowment fund signals growth in
   healthcare industry.
 * Japan accounts for 4.7% of global clinical trial activity in 2022.
 * Japan's developed healthcare system and ageing population increase demand for
   new treatments.
 * Sakigake package accelerates drug and device approvals in Japan.
 * Japanese Ministry of Health promotes innovation in pharmaceutical
   manufacturing.

CAPABILITIES

 * Partner depot in Japan obtained Green Management Certificate.
 * Global logistics network with depots and cold chain infrastructure.
 * Facilities comply with GDSP and GMP standards and offer advanced temperature
   control technology for cold chain solutions.
 * Smart Sourcing Solution for exclusive access to medicines and controlled
   drugs.
 * High standards of quality maintained, meeting GDP, GMP, CSV, and HSE
   requirements.


SOLUTIONS

View All

At Zuellig Pharma, we bridge the gap between clients and customers in the
healthcare value chain by providing customised and innovative healthcare
solutions that ensure unbeatable access to care throughout Asia.

Menu
 * Distribution
 * ZP Therapeutics
 * Clinical Reach
 * Technology Solutions
 * Patient Solutions

State-of-the-art end-to-end distribution solutions across 13 markets
Distribution
Experience unparalleled access to the healthcare market with Zuellig Pharma. Our
comprehensive range of pharmaceutical distribution services and tailored
healthcare solutions empower your business to reach its full potential. As a
trusted leader in the industry, Zuellig Pharma delivers custom healthcare
solutions that meet your unique needs.
Discover More
Understands consumers, customers and market in Asia
ZP Therapeutics
Zuellig Pharma is your trusted commercialisation partner in the healthcare
industry. We specialize in delivering innovative pharma solutions to enhance
patient access to care. Our flexible partnership models cater to diverse client
needs. With extensive expertise in Asia, we provide regulatory and governmental
affairs support, along with sales and marketing strategies to help businesses
expand their reach and impact.
Discover More
The future of clinical trials is brighter than ever.
Clinical Reach
Partner with Zuellig Pharma for seamless management of clinical trial supply
chains. From regional studies to complex global multi-center trials, our
expertise spans diverse scales. With our global product sourcing, integrated
storage and pharmaceutical distribution solutions, and localized returns
management, we ensure compliance with local and international healthcare
regulations for your clinical needs.
Discover More
Your digital platform of choice
Technology Solutions
Revolutionise Asia's healthcare ecosystem with Zuellig Pharma's innovative
pharmaceutical software platforms. Our advanced solutions bridge the gaps,
enhancing access and outcomes for clients, healthcare professionals, and
patients. With cutting-edge technology, businesses can streamline operations,
expand their reach, and deliver the care patients deserve.
Discover More
Personalised and innovative healthcare support
Patient Solutions
Experience patient-centric care with Zuellig Pharma's Patient Solutions
platform. Our personalised healthcare solutions and support empower patients to
take control of their well-being. With innovative features like mobile apps,
home care services, and disease management programs, we enhance the patient
experience and improve health outcomes.
Discover More

SEGMENTS

Long and lasting relationships with leading healthcare pharmaceutical companies
across multiple industry verticals.
 * Pharmaceuticals
 * Consumer Healthcare
 * Animal Health
 * Specialty Care
 * Medical Devices & Diagnostics
 * Vaccines


GET IN TOUCH

Reach out to us today and start a conversation.
Contact Us


TECHNOLOGY SOLUTIONS

View All
Digital technologies are at the core of our services. Learn how governments and
partner companies are driving efficiency and effectiveness with Zuellig Pharma.


EZTRACKER

eZTracker by Zuellig Pharma is an advanced supply chain management solution that
helps businesses track and monitor their healthcare products in real-time. 
Visit eZTracker


EZRX

eZRx by Zuellig Pharma is a cutting-edge platform that streamlines
pharmaceutical ordering and delivery processes. eZRx enables seamless
communication between healthcare professionals and suppliers for efficient &
effective medication management.

Visit eZRx


ABOUT US

We provide world-class distribution, technology, commercial, and integrated
health solutions and services to support the growing healthcare needs in this
region. The company was started a hundred years ago and has grown to become a
multi-billion dollar business covering 16 markets with over 12,000 employees.

Learn About Zuellig Pharma


SUSTAINABILITY

At Zuellig Pharma, we prioritise sustainability for a healthier future through
ethical business practices, resource conservation, and community support. Our
EcoVadis Platinum Rating for 2023 showcases our dedication to pursuing a better
tomorrow for our generation and beyond.
See Our Impact


NEWS AND INSIGHTS

View All

Discover what Zuellig Pharma is doing across the globe.

ZUELLIG PHARMA CEO JOHN GRAHAM APPOINTED A MEMBER OF 2024 BOARD OF THE US-ASEAN
BUSINESS COUNCIL

Zuellig Pharma CEO John Graham has been appointed a member of the 2024 Board of
the US-ASEAN Business Council, which steers regional shifts with research and
analysis of economic, ...

ZUELLIG PHARMA AND SUBSTIPHARM BIOLOGICS PARTNER TO EXPAND ACCESS TO IMOJEV®
VACCINE FOR JAPANESE ENCEPHALITIS ACROSS ASIA

Zuellig Pharma, a leading healthcare solutions company in Asia, has announced
its commercialisation partnership with pharmaceutical company Substipharm
Biologics, to expand access of the IMOJEV® Japanese encephalitis vaccine across
nine markets in Asia, including Brunei, Cambodia, Hong Kong, Malaysia, Myanmar,
Philippines, Singapore, Taiwan and Vietnam. 

ZUELLIG PHARMA BECOMES STADA PHILIPPINES’ EXCLUSIVE DISTRIBUTION PARTNER

Leading healthcare solutions company, Zuellig Pharma to exclusively distribute
STADA Philippines’ range of consumer healthcare and prescription products in
local market    ...

ZUELLIG PHARMA PARTNERS WITH ACEN RES TO SUPPLY 100% RENEWABLE ENERGY TO TWO KEY
DISTRIBUTION FACILITIES IN THE PHILIPPINES

Zuellig Pharma, Asia’s leading healthcare solutions company, has recently signed
a new strategic partnership with ACEN Renewable Energy Solutions (ACEN RES), the
retail electricity arm of ACEN,...

ZUELLIG PHARMA AWARDED ECOVADIS PLATINUM MEDAL FOR THIRD CONSECUTIVE YEAR AND
RATED LEADER IN CARBON MANAGEMENT

Zuellig Pharma, a leading healthcare solutions company in Asia, has announced
that it has achieved the platinum medal from EcoVadis, the world’s most trusted
provider of business sustainability ratings, for the third consecutive year.

ZUELLIG PHARMA SINGAPORE AND GSK ESTABLISH VACCINE DISTRIBUTION HUB TO IMPROVE
ASIA’S ACCESS TO VACCINES

Zuellig Pharma, one of the largest healthcare services groups in Asia, today
announced that it has entered into an agreement with global biopharma company,
GSK, to help set up its first vaccine...

INTERPHARMA INVESTMENTS LIMITED APPOINTS ALFONSO “CHITO” ZULUETA AS
NON-EXECUTIVE CHAIRMAN

Interpharma Investments Limited, holding company of leading healthcare services
provider Zuellig Pharma, today announced the appointment of Mr. Alfonso “Chito”
Zulueta as Non-Executive Chairman...

ZUELLIG PHARMA RECOGNISED WITH A SCORE OF “A-” ON CDP SUPPLIER ENGAGEMENT IN
INDUSTRY FIRST

Zuellig Pharma, one of the largest healthcare services groups in Asia, has
announced its score of “A-” for Supplier Engagement from global carbon
disclosure platform CDP, making it the first...

COVID-19 VACCINES CLINICAL TRIAL ENVIRONMENT

The World Health Organization officially declared the coronavirus outbreak a
pandemic in March 2020. By June 2021, 170 vaccine candidates for COVID-19 had
been developed. Of these, 90 were...

ZUELLIG PHARMA BRINGS LOGISTICS EXPERTISE TO SUPPORT THE THAI GOVERNMENT IN
DISTRIBUTION OF ONE MILLION DOSES OF COVID -19 VACCINE MODERNA DONATED BY THE US
GOVERNMENT FOR THAI PEOPLE

Zuellig Pharma announced its commitment to support the Thai Government, through
the Department of Disease Control, Ministry of Public Health. Zuellig Pharma
will provide warehousing and ...

ZP THERAPEUTICS READY TO DELIVER THE FIRST SHIPMENT OF COVID-19 VACCINE MODERNA
TO INCREASE VACCINE ACCESS IN THAILAND

The Government Pharmaceutical Organisation, represented by Ms. Sirikul
Matevelungsun (third from left), Deputy Managing Director, together with The
Private Hospital Association, represented by...

ZUELLIG PHARMA AND GW PHARMACEUTICALS SIGN A PARTNERSHIP AGREEMENT IN TAIWAN

Zuellig Pharma announced a new partnership with GW Pharmaceuticals (GW) to
support access to cannabis-based medicines in Taiwan. GW, part of Jazz
Pharmaceuticals plc, is a world leader in...

UPDATES ON THE FIRST SHIPMENT OF COVID-19 VACCINE MODERNA TO THAILAND

ZP Therapeutics, a division of Zuellig Pharma and the official partner of
Moderna in Thailand, confirms that the first shipment of 560,000 doses of
COVID-19 Vaccine Moderna will arrive in...

DEPARTMENT OF DISEASE CONTROL APPOINTS ZUELLIG PHARMA TO HANDLE 20 MILLION DOSES
PFIZER-BIONTECH COVID-19 VACCINES IN THAILAND

Zuellig Pharma has been appointed by the Department of Disease Control to handle
and distribute another 20 million doses of the Pfizer-BioNTech COVID-19 vaccines
in Thailand. The vaccines will...

MAKING GOOD MENTAL HEALTH A REALITY

By Jen Garcia, VP Human Resources & Corporate Communications Technology like
smartphones, laptops and smartwatches have blurred the lines between work and
personal time even...

ZUELLIG PHARMA RECEIVES ECOVADIS PLATINUM SUSTAINABILITY RATING FOR THE YEAR
2021

Zuellig Pharma has been awarded the Platinum Medal 2021 by sustainability
ratings specialist EcoVadis. The award is the highest accolade to be awarded to
a company for its sustainability ...

CHULABHORN ROYAL ACADEMY SIGNS AGREEMENT WITH ZUELLIG PHARMA TO PURCHASE EIGHT
MILLION DOSES OF COVID-19 VACCINE MODERNA

  The Chulabhorn Royal Academy (CRA) announced an official agreement with ZP
Therapeutics, a division of Zuellig Pharma on the supply and distribution of
eight million doses of the...

THAILAND'S FOOD AND DRUG ADMINISTRATION EXPANDS AUTHORISATION OF COVID -19
VACCINE MODERNA FOR USE IN ADOLESCENTS 12 TO 17 YEARS OLD

ZP Therapeutics, a division of Zuellig Pharma today announced that Thailand Food
and Drug Administration (FDA) has expanded the authorisation of the COVID-19
Vaccine Moderna for use ...

ZUELLIG PHARMA WINS FOUR AWARDS AT THE ASIA CORPORATE EXCELLENCE &
SUSTAINABILITY AWARDS 2021

Zuellig Pharma, a leading healthcare services provider in Asia, has been
presented with four leadership and sustainability awards, in both individual and
enterprise categories, at...

ZUELLIG PHARMA THAILAND COLLABORATES WITH THE DEPARTMENT OF DISEASE CONTROL
(DDC) TO PROVIDE NATIONWIDE DISTRIBUTION SERVICES OF 1.5MILLION DOSES OF
PFIZER-BIONTECH COVID -19 MRNA VACCINES

Vaccines will be stored between -80°C and -60°C Zuellig Pharma Thailand has
collaborated with the Department of Disease Control (DDC) Thailand to distribute
1.5million doses ...

1 / 7
Our website uses cookies to personalise content and ads, analyse traffic, and
improve your browsing experience. By clicking 'Accept', you consent to the use
of cookies and the processing of your personal data. Learn more in our privacy
policy and cookie policy.
Accept


LET'S CONNECT AND GET STARTED TODAY!

Select one...
 * General
 * Report concerns (Whistleblowing)

Contact Us
Hidden




Zuellig Pharma is a leading healthcare solutions company offering a broad range
of solutions with a mission to make healthcare more accessible.

About Us Purpose & Core Values Leadership Heritage & Milestones Ethics &
Compliance Quality Sustainability Procurement
Segments Pharmaceuticals Medical Devices & Diagnostics Consumer Healthcare
Animal Health Specialty Care Vaccines
Solutions Distribution ZP Therapeutics Clinical Reach Technology Solutions
Patient Solutions Regulatory Services
News & Insights Careers Contact Us

© Zuellig Pharma. All rights reserved.

Privacy Policy Legal Disclaimer Cookies

47 Scotts Road #10-00 Goldbell Towers Singapore 228233

Powered by Liferay